AstraZeneca faces potential fines in China over import taxes

It came as the Cambridge-based firm revealed strong sales of cancer drugs helped drive revenues higher.

Feb 6, 2025 - 10:01
 0
AstraZeneca faces potential fines in China over import taxes
It came as the Cambridge-based firm revealed strong sales of cancer drugs helped drive revenues higher.